COMMUNIQUÉS West-GlobeNewswire

-
Bluejay Therapeutics Reports First Preclinical Data for Liver-Targeted Fatty Acid Synthase (FASN) Inhibitor BJT-188 Being Investigated for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
07/05/2025 -
Late-breaking exploratory data highlights the impact of IQIRVO® (elafibranor) on fatigue and provides mechanistic insights into anti-inflammatory and symptom-related effects in patients with primary biliary cholangitis
07/05/2025 -
De nouvelles données issues d’analyses exploratoires soulignent l’impact d’IQIRVO® (élafibranor) sur la fatigue et mettent en lumière son mécanisme d’action sur l’inflammation et les symptômes associés à la cholangite biliaire primitive
07/05/2025 -
Trogenix Further Strengthens its Scientific Advisory Board with the Appointment of World-Leading Experts, Prof Nada Jabado and Prof Burkhard Becher
07/05/2025 -
Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025
07/05/2025 -
CROSSJECT provides updates on the EUA filing of ZEPIZURE®
07/05/2025 -
CROSSJECT fait un point sur les dernières avancées dans le dépôt de la demande EUA de ZEPIZURE®
07/05/2025 -
Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates
07/05/2025 -
Valneva publie ses résultats financiers du premier trimestre 2025 et fait un point sur son activité
07/05/2025 -
CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105
07/05/2025 -
PrimeBiome Reviews Consumer Reports: Critical Complaints & Customer Reviews Exposed!
07/05/2025 -
BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
07/05/2025 -
Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference
07/05/2025 -
Dogecoin Cash, Inc. Confirms Stock Dividend Record and Payment Dates; FINRA Publication Completed
07/05/2025 -
Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results
07/05/2025 -
Dunham House Breaks Ground on Transformational Housing for Combat-Wounded Veterans
06/05/2025 -
WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability
06/05/2025 -
Extendicare Announces 2025 First Quarter Results
06/05/2025 -
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2025 Financial Results on May 8, 2025
06/05/2025
Pages